Intimate hygiene and care


Intimate Lubricant specially developed to provide immediate lubrication and deep moisture during intercourse
The vaginal lubricant gel is recommended in the event of discomfort during sexual intercourse.
The intimate lubricant is formulated with 2 types of hyaluronic acid for complementary and optimum efficacy:
High molecular weight hyaluronic acid allows immediate lubrication by forming a film on the surface of the mucosa.
Medium molecular weight hyaluronic acid provides lasting moisturising by acting deeply as a water collector.

Its unique formula is also composed of natural extracts of Burdock to soothe and Aloe Vera to moisturise.

Available in a single dose format that can be opened with one hand for greater convenience and discretion.


Available in 2 formats:
> Pump dispenser 30ml: EAN 3401040395076
> Box of 15 unidoses : EAN 3401021525539


Proven efficacy*

Over 1 in 2 women

experience greater pleasure


of women are satisfied


of women recommend it

For optimum tolerance

Colourless and odourless formula.

Non-sticky, does not stain. Fragrance-free, colourant-free.

Tested under medical supervision.
Compatible with condoms.



Burdock is a plant native to Asia and Europe, renowned for its softening and soothing properties. The burdock roots (Arctium lappa root) used are carefully selected by Saforelle.
Hyaluronic acid


L’Aloe Vera

Ingredients: Water, glycerol, pentylene glycol, hyaluronic acid sodium salt, hydroxy ethyl cellulose, sodium alginate, ethylhexy glycerine, burdock extract, potassium sorbate, nicotinamide, aloe vera gel, lactic acid.

Recommendations for use

Use Saforelle lubricant before or during sexual intercourse. Apply the necessary amount of gel to the external mucous membranes and at the entrance to the vagina. Both partners can use the gel.

Expert advices

For more informations:

*Efficacy and tolerance of lubricant moisturising Saforelle gel in patients suffering from dyspareunia or vaginal discomfort. Application before or during sexual intercourse in 32 women over 2 months. Study Report 05/2019.
**Formulated to minimise the risk of allergy.
Class II a medical device, CE0459, read the leaflet carefully